Early results from a double-blind, randomized phase IIB trial of difluoromethylorthine plus sulindac for colon cancer prevention.

被引：0
|
作者：
Meyskens, FL
Pelot, D
MacLaren, CE
Lagerberg, W
Li, KT
Carpenter, P
Gerner, E
Goldschmid, S
Kidao, J
Ahnen, D
Lawson, MJ
McCracken, J
机构：
[1] Chao Family Comprehens Canc Ctr, Orange, CA USA
[2] Univ Calif Irvine, Irvine, CA USA
[3] Arizona Canc Ctr, Tucson, AZ USA
[4] Long Beach VA Med Ctr, Long Beach, CA USA
[5] Univ Colorado, Sch Med, Denver, CO USA
[6] Kaiser Permanente, Sacramento, CA USA
[7] Loma Linda Univ, Loma Linda, CA 92350 USA
[8] Pettis VA Med Ctr, Loma Linda, CA USA
来源：
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 2004年 / 13卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1904S / 1904S
页数：1
相关论文
共 50 条
  • [31] TAMOXIFEN PLUS BROMOCRIPTINE VERSUS TAMOXIFEN ALONE IN ADVANCED BREAST-CANCER - RESULTS OF A MULTICENTER DOUBLE-BLIND RANDOMIZED TRIAL
    BONNETERRE, J
    MAURIAC, L
    WEBER, B
    ROCHE, H
    FARGEOT, P
    TUBIANA, M
    SEVIN, M
    CHOLLET, P
    CAPPELAERE, P
    BULLETIN DU CANCER, 1988, 75 (07) : 654 - 654
  • [32] Marked efficacy of difluoromethylornithine (DFMO) plus sulindac in reducing recurrent colorectal adenomas in patients with prior adenomas: Results of a randomized, placebo-controlled double-blind trial
    Pelot, Daniel
    Meyskens, Frank L.
    Gerner, Eugene
    McLaren, Christine E.
    Fujikawa-Brooks, Sharon E.
    Lawson, Michael J.
    Kidao, Jayashri
    McCracken, John
    Griffin, Ronald
    Albers, C. G.
    Carpenter, Philip
    Ahnen, Dennis
    Turgeon, D. K.
    Hagedorn, Curt H.
    GASTROENTEROLOGY, 2008, 134 (04) : A113 - A114
  • [33] SWOG S0820/PACES (Preventing Adenomas of the Colon with Eflornithine and Sulindac): A randomized, double-blind, placebo-controlled phase III clinical trial.
    Zell, Jason A.
    Unger, Joseph M.
    Anderson, Garnet L.
    Cook, Elise D.
    Krouse, Robert S.
    Lance, M. Peter
    Minasian, Lori M.
    Ford, Leslie
    Brown, Powel
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [34] Response to topiramate in the prevention of chronic migraine: results of a double-blind, randomized, placebo-controlled trial
    Grazzi, L.
    Diener, H-C
    Van Oene, J. C.
    Lahaye, M.
    Schwalen, S.
    Goadsby, P. J.
    CEPHALALGIA, 2006, 26 (11) : 1368 - 1368
  • [35] DOUBLE-BLIND, RANDOMIZED TRIAL OF PIROXICAM AND CODEINE IN CANCER PAIN
    STAQUET, M
    RENAUD, A
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1993, 53 (04): : 435 - 440
  • [36] Lecanemab Clarity AD: Quality-of-Life Results from a Randomized, Double-Blind Phase 3 Trial in Early Alzheimer's Disease
    Cohen, Sharon
    van Dyck, C. H.
    Gee, M.
    Doherty, T.
    Kanekiyo, M.
    Dhadda, S.
    Li, D.
    Hersch, S.
    Irizarry, M.
    Kramer, L. D.
    JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2023, 10 (4): : 771 - 777
  • [37] Lecanemab Clarity AD: Quality-of-Life Results from a Randomized, Double-Blind Phase 3 Trial in Early Alzheimer’s Disease
    Sharon Cohen
    C. H. van Dyck
    M. Gee
    T. Doherty
    M. Kanekiyo
    S. Dhadda
    D. Li
    S. Hersch
    M. Irizarry
    L. D. Kramer
    The Journal of Prevention of Alzheimer's Disease, 2023, 10 : 771 - 777
  • [38] RESULTS OF A PROSPECTIVE RANDOMIZED DOUBLE-BLIND TRIAL OF APROTININ IN COLONIC SURGERY
    YOUNG, HL
    WHEELER, MH
    CLARK, CG
    HAMPSON, LG
    WORLD JOURNAL OF SURGERY, 1984, 8 (03) : 367 - 373
  • [39] Results of double-blind randomized trial: The Elderly and Lercanidipine (ELLE) study
    Cherubini, A
    Senin, U
    AMERICAN JOURNAL OF HYPERTENSION, 2003, 16 (05) : 189A - 189A
  • [40] Etanercept for refractory ocular sarcoidosis - Results of a double-blind randomized trial
    Baughman, RP
    Lower, EE
    Bradley, DA
    Raymond, LA
    Kaufman, A
    CHEST, 2005, 128 (02) : 1062 - 1067
12345